Efficacy of USG-guided platelet rich plasma injection in supraspinatus muscle tears and follow-up in terms of improvement in shoulder pain and MRI findings

Efficiency of USG-guided platelet rich plasma injection in the management of radiologically proven partial thickness supraspinatus tears. - Efficiency of USG-guided PRP injection in the management of radiologically proven partial thickness supraspinatus tears.

Status

Recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/054824

Enrollment

Registered

2023-07-06

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Z00-Z99- Factors influencing health status and contact with health services Health Condition 2: S460- Injury of muscle(s) and tendon(s)of the rotator cuff of shoulder Health Condition 3: S460- Injury of muscle(s) and tendon(s)of the rotator cuff of shoulder

Interventions

Intervention1: Platelet rich plasma: A single dose of 8 ml platelet rich plasma is infiltrated in the tendon sheath of supranational tendon and in the intermuscular planes between supraspinatus and de

Eligibility

Inclusion criteria

Inclusion criteria: the patients with chronic joint pain being referred for imaging. patients found to have partial thickness supraspinatus tear on MRI. patient consenting to USG guided PRP injection.

Exclusion criteria

Exclusion criteria: Patient found to have complete supraspinatus tear and involvement of other rotator cuff muscles on MRI shoulder. patient with shoulder dislocation. patient with adhesive capsulitis. patient with prior shoulder surgery. arthritis of shoulder joint.

Design outcomes

Primary

Measure	Time frame
Clinical improvement of shoulder pain and disability as assessed by SPADI score and its MRI correlation.Timepoint: At 1 month and 6 months	—

Secondary

Measure	Time frame
to look for any new adverse effects post PRP injection.Timepoint: 6 months	—

Countries

India

Contacts

Public Contactpratibha mishra

command hospital central command, lucknow

nkj7245y@rediffmail.com9764624952

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026